Literature DB >> 3184611

Inducing hyperkalemia by converting enzyme inhibitors and heparin.

D Durand1, J L Ader, J P Rey, T Tran-Van, J J Lloveras, P Bernadet, J M Suc.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3184611

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  7 in total

1.  Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.

Authors:  Olga H Torres; Nerea Hernandez; Esther Francia; Montserrat Barcelo; Jose Mateo; Domingo Ruiz
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Hospital-acquired hyperkalaemia.

Authors:  N C Bacon
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

Review 3.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

Review 4.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 5.  Clinical features and management of poisoning due to potassium chloride.

Authors:  K Saxena
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 6.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

7.  Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.

Authors:  Nima Melzer; Peter Bramlage; Hans-Christoph Michaelis
Journal:  BMC Res Notes       Date:  2014-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.